Estrogen Receptor-negative Breast Cancer Terminated Phase 2 Trials for Entinostat (DB11841)

IndicationStatusPhase
DBCOND0028543 (Estrogen Receptor-negative Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01234532Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by SurgeryTreatment